Senores Pharmaceuticals Limited — Updates, 05-05-2025: Press Release

Senores Pharmaceuticals has announced a board meeting on the financial results for the quarter and half-year. Its US subsidiary acquired the USFDA-approved ANDA for Topiramate HCl tablets from Wockhardt, targeting a US market valued at USD 111.47 million. Funded via IPO proceeds, this move enhances Senores’ presence in the US complex generics segment, supporting growth in a high-potential therapeutic area.